STAT+: Like Merck, Pfizer strikes a licensing deal with the Medicines Patent Pool for a Covid-19 pill
Amid considerable anticipation over its Covid-19 pill, Pfizer (PFE) reached a licensing agreement with the Medicines Patent Pool, which in turn can now strike deals with other manufacturers to provide versions of the drug to 95 low and middle-income countries.
The agreement follows a similar arrangement with Merck (MRK) concerning its own antiviral pill for combating the coronavirus. Notably, this also marks only the second time that a pharmaceutical company has struck a licensing deal with the Medicines Patent Pool — a public health organization backed by the United Nations — to widen access to a Covid-19 medical product.
Continue to STAT+ to read the full story…
